Mankhwala a urticaria amadalira pa kuopsa kwa vutolo ndi chifukwa chake.
Nazi njira zina zofala zochiritsira:
1. Mankhwala a antihistamines: Mankhwalawa amathandiza kuchepetsa kuyabwa ndi kutupa mwa kuletsa zotsatira za histamine, mankhwala amene thupi limatulutsa pamene munthu ali ndi vuto la chifuwa.
M'milandu yoopsa kwambiri, dokotala angapereke mankhwala amphamvu a antihistamines.
2. Corticosteroids: M'zochitika zimene antihistamines sizigwira ntchito, corticosteroids monga prednisone angalembedwe kuti achepetse kutupa ndi kuchepetsa chitetezo cha m'thupi.
Mankhwala ameneŵa kaŵirikaŵiri amamwa mwa pakamwa ndipo angapereke mpumulo mwamsanga.
3. Mankhwala oletsa chitetezo cha m'thupi: M'milandu ya urticaria yosatha imene siiyankha ku mankhwala ena, mankhwala oletsa chitetezo cha m'thupi monga cyclosporine kapena methotrexate angalembedwe kuti aletse chitetezo cha m'thupi ndi kuchepetsa kutupa.
4. Omalizumab: Mankhwalawa ndi ma antibody a monoclonal omwe amalowetsedwa m'magazi omwe amayang'ana ndi kuletsa immunoglobulin E (IgE), mapuloteni omwe amatenga nawo mbali pamachitidwe a chifuwa.
Kaŵirikaŵiri amagwiritsidwa ntchito pa urticaria yosatha imene siimayankha ku mankhwala ena.
5. Pewani zinthu zimene zingayambitse matenda a urticaria: Kuzindikira ndi kupewa zinthu zimene zingayambitse matenda a urticaria kungathandize kupewa matenda a urticaria.
Zinthu zimene zimayambitsa matendawa ndi monga zakudya zina, mankhwala, kulumidwa ndi tizilombo, kutentha, kuzizira, kapena kuwala kwa dzuŵa.
Deleanu D, Nedelea I, Petricau C, Leru P, Dumitrascu D, Muntean A: Clinical impact of omalizumab in refractory chronic urticaria: One centre experience. Exp Ther Med. 2019, 18 (6): 5078-5081.
Grundmann SA, Kiefer S, Luger TA, Brehler R: Delayed pressure urticaria - dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011, 9 (11): 908-12.
Staumont-Sallé D, Piette F, Delaporte E: [Etiological diagnosis and treatment of chronic urticaria]. Rev Med Interne. 2003, 24 (1): 34-44.
Akashi R, Ishiguro N, Shimizu S, Kawashima M: Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011, 38 (8): 761-6.
Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG: Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem. 2020, 19 (3): 335-339.
Chodzikanira: zachipatala
Webusaitiyi imaperekedwa kaamba ka zolinga za maphunziro ndi chidziŵitso zokha ndipo si kupereka uphungu wa zachipatala kapena mautumiki a akatswiri.
Chonde dziŵani kuti ma neural net amene amapanga mayankho a mafunso, ndi osayenerera makamaka pankhani ya manambala. Mwachitsanzo, chiŵerengero cha anthu odwala matenda enaake.
Nthawi zonse funsani upangiri wa dokotala wanu kapena wothandizira wina waluso pankhani ya matenda. Musanyalanyaze upangiri wa zamankhwala kapena kuchedwetsa kufunafuna chifukwa cha china chake chomwe mwawerenga patsamba lino. Ngati mukuganiza kuti mungakhale ndi vuto ladzidzidzi, itanani 911 kapena pitani ku chipinda chadzidzidzi chapafupi nthawi yomweyo. Palibe ubale wa dokotala ndi wodwala womwe umapangidwa ndi tsamba ili kapena kugwiritsa ntchito kwake. Neither BioMedLib kapena antchito ake, kapena aliyense wothandizira patsamba lino, amapanga ziwonetsero zilizonse, zowonetsera kapena zomveka, zokhudzana ndi chidziwitso choperekedwa pano kapena kugwiritsa ntchito kwake.
Chodzikanira: ufulu wolemba
Lamulo la Digital Millennium Copyright Act la 1998, 17 U.S.C. § 512 (the DMCA) limapereka njira yothandizira eni ake omwe amakhulupirira kuti zinthu zomwe zikuwonekera pa intaneti zimaphwanya ufulu wawo pansi pa lamulo la copyright la US.
Zidziwitso ziyenera kutumizidwa polemba kudzera pa imelo (onani gawo la "Contact" pa adilesi ya imelo).
DMCA imafuna kuti chidziwitso chanu cha kuphwanya ufulu waumwini chiphatikizepo chidziwitso chotsatirachi: (1) kufotokoza kwa ntchito yotetezedwa ndi ufulu waumwini yomwe ndi nkhani ya kuphwanya ufulu waumwini; (2) kufotokoza kwa zomwe zikunenedwa kuti zikuphwanya ufulu waumwini ndi chidziwitso chokwanira kutilola kupeza zomwe zili; (3) zidziwitso zolumikizirana nanu, kuphatikiza adilesi yanu, nambala yafoni ndi adilesi ya imelo; (4) mawu anu oti muli ndi chikhulupiriro chabwino kuti zomwe zili m'njira yomwe akudandaula sizinaloledwe ndi mwiniwake wa ufulu waumwini, kapena wothandizila wake, kapena chifukwa cha lamulo lililonse;
(5) chikalata chanu, chosainidwa pansi pa chilango cha umboni wabodza, chakuti chidziŵitso chimene chili m'chidziŵitsocho n'cholondola ndipo kuti muli ndi ulamuliro wokakamiza kukhazikitsa ufulu waumwini umene akunena kuti waphwanyidwa;
ndi (6) siginecha yakuthupi kapena yamagetsi ya mwiniwake wa ufulu waumwini kapena munthu wololedwa kuchitapo kanthu m'dzina la mwiniwake wa ufulu waumwini.
Chonde titumizireni imelo ndi funso / lingaliro lililonse.
How to treat urticaria?
Urticaria, commonly known as hives, is a skin condition characterized by itchy, raised welts that can appear on any part of the body.
It can be caused by various factors, including allergic reactions, infections, or underlying medical conditions.
Treatment for urticaria depends on the severity of the condition and the underlying cause.
Here are some common treatment options:
1. Antihistamines: These medications help to reduce itching and swelling by blocking the effects of histamine, a chemical released by the body during an allergic reaction.
Over-the-counter antihistamines such as diphenhydramine (Benadryl) or loratadine (Claritin) can be effective in mild cases.
In more severe cases, a doctor may prescribe stronger antihistamines.
2. Corticosteroids: In cases where antihistamines are not effective, corticosteroids such as prednisone may be prescribed to reduce inflammation and suppress the immune system.
These medications are usually taken orally and can provide quick relief.
3. Immunosuppressants: In cases of chronic urticaria that do not respond to other treatments, immunosuppressant drugs such as cyclosporine or methotrexate may be prescribed to suppress the immune system and reduce inflammation.
4. Omalizumab: This medication is an injectable monoclonal antibody that targets and blocks immunoglobulin E (IgE), a protein involved in allergic reactions.
It is typically used for chronic urticaria that does not respond to other treatments.
5. Avoid triggers: Identifying and avoiding triggers that cause urticaria can help prevent outbreaks.
Common triggers include certain foods, medications, insect bites, and exposure to heat, cold, or sunlight.
6. Cold compress: Applying a cold compress to the affected area can help reduce itching and swelling.
7. Wet wraps: Wet wraps can be used to soothe itching and reduce inflammation.
A damp cloth is wrapped around the affected area, and then a dry cloth is placed over it to retain moisture.
8. Phototherapy: Exposure to ultraviolet light can help suppress the immune system and reduce inflammation in some cases of chronic urticaria.
It is important to consult a healthcare professional for proper diagnosis and treatment of urticaria.
They can help determine the underlying cause and recommend the most appropriate treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Pafupifupi
BioMedLib imagwiritsa ntchito makompyuta othandizira (ma algorithms ophunzirira makina) kuti apange mafunso ndi mayankho awiri.
Timayamba ndi zofalitsa za mankhwala a zamoyo zokwana 35 miliyoni za PubMed/Medline. Komanso, masamba a webusaiti ya RefinedWeb.
